Skip to main content

and
  1. Article

    Open Access

    Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis

    Upregulation of the mitogen-activated protein kinase (MAPK) cascade is common in hepatocellular carcinoma (HCC). Neuroblastoma RAS viral oncogene homolog (NRAS) is mutated in a small percentage of HCC and is hith...

    Sophie Klemm, Katja Evert, Kirsten Utpatel, Alexandra Muggli, Maria M. Simile in BMC Cancer (2023)

  2. Article

    Open Access

    Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre

    Recently, molecular tumour boards (MTBs) have been integrated into the clinical routine. Since their benefit remains debated, we assessed MTB outcomes in the Comprehensive Cancer Center Ostbayern (CCCO) from 2...

    Alexander Scheiter, Frederik Hierl, Florian Lüke, Felix Keil in British Journal of Cancer (2023)

  3. Article

    Open Access

    Functional role of SGK3 in PI3K/Pten driven liver tumor development

    Hepatocellular carcinoma (HCC) is a leading cause of cancer related deaths worldwide. The PI3K cascade is one of the major signaling pathways underlying HCC development and progression. Activating mutations of...

    Hui Cao, Zhong Xu, **gxiao Wang, Antonio Cigliano, Maria G. Pilo in BMC Cancer (2019)

  4. Article

    Open Access

    Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice

    Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide with limited treatment options. Mutation of β-catenin is one of the most frequent genetic events along hepatocarcin...

    Yu Qiao, Meng Xu, Junyan Tao, Li Che, Antonio Cigliano, Satdarshan P Monga in BMC Cancer (2018)

  5. Article

    Open Access

    Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway

    Hepatocellular carcinoma (HCC) is a deadly malignancy with limited treatment options. Activation of the AKT/mTOR cascade is one of the most frequent events along hepatocarcinogenesis. mTOR is a serine/threonin...

    Zhong Xu, Junjie Hu, Hui Cao, Maria G Pilo in Experimental & Molecular Medicine (2018)

  6. No Access

    Article

    A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

    The variability in the prognosis of individuals with hepatocellular carcinoma (HCC) suggests that HCC may comprise several distinct biological phenotypes. These phenotypes may result from activation of differe...

    Ju-Seog Lee, Jeonghoon Heo, Louis Libbrecht, In-Sun Chu in Nature Medicine (2006)

  7. No Access

    Article

    Application of comparative functional genomics to identify best-fit mouse models to study human cancer

    Genetically modified mice have been extensively used for analyzing the molecular events that occur during tumor development. In many, if not all, cases, however, it is uncertain to what extent the mouse models...

    Ju-Seog Lee, In-Sun Chu, Arsen Mikaelyan, Diego F Calvisi, Jeonghoon Heo in Nature Genetics (2004)